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Genetic Basis of the Dominant-Lethal
Test
Potential genetic hazards due to drugs
and chemical pollutants are now generally
recognized. Such recognition has been paral-
leled by the recent development of appropri-
ate sensitive, and practical in vivo mamma-
lian methods for detecting and measuring
mutagenic effects due to chemicals (1,2).
These methods have a high degree of pre-
sumptive human relevance and include in vivo
cytogenetics, the host-mediated assay, and the
dominant-lethal assay; submammalian sys-
tems are generally considered' to yield -data
of ancillary value (3). An expert HEW com-
mittee has recently recommended that drugs,
pesticides, food additives and other synthetic
chemicals be tested for mutagenicity in mam-
malian systems prior to their use or registra-
tion (1).
Dominant-lethal mutations have been used
as convenient indicators of major genetic
damage for measuring the effects of x-ray
and of mutagenic chemicals in mammals.
Such data may be appropriately extrapolated
to man, especially as many recognizable hu-
man autosomal traits are due to dominant
mutations (4).
The genetic basis for dominant lethality
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is mainly the induction of structural and
numerical chromosomal anomalies, such as
translocations and aneuploidies (Table 1);
sequentially, these may induce preimplanta-
tion losses of nonviable zygotes, early fetal
deaths, and sterility and semisterility in F'
progeny (5-9). Translocations have been
identified in F1 progeny of mutagen-treated
male rodents (7-11) and also in human
abortions and congenital malformations (12).
Table 1. Genetic basis of the dominant test.
Presumed Associated
genetic basis genetic anomalies
Aneuploidy Sterility and semisterility
Deficiencies: unhealed Viable reciprocal translo-
chromosome breaks cations in F1 progeny
Reciprocal transloca- Cytogenetic effects in
tions early cleavage and
live embryos
The Dominant-Lethal Test in Relation to
Standard Toxicological Practice
Assays should be conducted on both mice
and rats as standard toxicological practice.
Species variation in sensitivity has already
been noted (13); for example, DDT does not
induce either preimplantation losses or early
fetal deaths in mice (S. S. Epstein, unpub-
lished data) but does so in rats (M. Legator,
unpublished data). Chemicals should be
tested for mutagenicity after acute, subacute
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testing in male mice (1£).
Administration Dose Dose
route schedule level Animals
Acute Oral or parenteral Single dose 0.2 LD50 Male mice mated with 3
females each for 5 suc-
cessive weeks
Subacute Oral or parenteral Daily for 5 days 0.2 LDo0 Male mice mated with 3
females each for 5 suc-
cessive weeks
Chronic Oral Dailyfor 3 months Maximally tolerated Male mice mated with 3
dose females each for 4 suc-
cessive weeks
and chronic administration to male rodents
by oral, parenteral, and respiratory routes
(Table 2).
The route of test should reflect human
exposure. Subacute testing is reco-mmended
largely to anticipate and reflect the role of
possible hepatic microsomal detoxification or
activation, while the object of chronic admin-
istration is to detect cumulative spermato-
gonial mutations. Enough animals must be
used so that a test which indicates differences
significant at the 5% level will have a 99%o
probability of detecting any true difference
that exceeds 20% of the control mean number
of living implants. For initial testing, a single
dose is adequate. In acute and subacute test-
ing, 0.2 of the LD50's are recommended, while
maximally tolerated doses are appropriate
for chronic testing (14).
In vivo mammalian tests for mutagenicity
could be practically and economically inte-
grated in routine toxicity testing. In acute,
subacute and chronic toxicity testing, for ex-
ample, or in the course of carcinogenicity
tests, male mice or rats may be mated with
untreated females which can subsequently
be examined for the induction of dominant
lethal mutations, indicated by early fetal
deaths and preimplantation losses. Cytogen-
etic analyses in rats can be performed seri-
ally on peripheral blood, on bone marrow,
and possibly on testes at death as a standard
procedure in toxicity testing. In this con-
text, it has recently been suggested that test-
ing for toxicity, teratogenicity, carcinogeni-
city and mutagenicity could be performed on
the same groups of animals (15). Finally,
in common with all toxicological procedures,
the protocols recommended here should dy-
namically reflect technical and conceptual
advances.
The "Conventional" Dominant-Lethal Test
In the conventional dominant-lethal assay
(8, 16), male mice or rats are dosed singly
with subtoxic concentrations of the drugs to
be tested. They are then mated sequentially
with groups of untreated females. Matings in
weeks 1-2, 3-4, and 5-8 after treatment of
male mice represent samples of postmeiotic,
meiotic, and premeiotic stages of spermato-
genesis, respectively; corresponding periods
in the rat are weeks 1-4, 5-6, and 7-10.
Timing of stage sensitivity can be compli-
cated by delayed metabolic activation or de-
toxification of the drug or by drug-induced
inhibition of mitosis or meioses. Females are
inspected daily for vaginal plugs, dissected
on approximately the fourteenth day of preg-
nancy, and scored for corpora lutea and for
total implants comprising early and late
fetal deaths and living foetuses. Mutagenic
effects are expressed conventionally as the
mutagenic index (early fetal deaths/total im-
plants) x 100.
The "Modified" Dominant-Lethal Test
The dominant-lethal assay has recently
been modified and simplified for large-scale
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spection for vaginal plugs is omitted; in-
stead, all females are dissected 13 days after
the midweek of their caging and presump-
tive mating. Corpora lutea counts, which are
difficult and relatively imprecise in mice, are
also omitted, and preimplantation losses are
scored by contrasting values of total implants
in females mated with treated and control
males. Use of the modified assay may be
recommended for routine screening in mice.
In rats, however, matings should be timed
and corpora lutea counted.
Detailed characterization of the reproduc-
tive parameters of large control populations
is essential to the development of standard
protocols for the dominant lethal assay (18).
Such studies will define the range and cyclic
variation in total implants, preimplantation
losses, and early and late fetal deaths. Closed-
colony, random-bred rodents are suitable for
these assays, and the use of F1 hybrids may
minimize variation.
Scoring for Results in the Dominant-
Lethal Test
Complete autopsy of females is essential,
as intercurrent infection in any animal can
induce preimplantation losses and early fetal
deaths (19). The induction of dominant-
lethal mutations is scored directly by an in-
creased incidence of early fetal deaths and
indirectly by an increased incidence of pre-
implantation losses, measured by the differ-
ence between total implants in control and
test females, and/or by the difference be-
tween corpora lutea counts and number of
total implants. Mutagenic effects may be
reported directly in terms of the mutagenic
index and/or as the number of early fetal
deaths per pregnant mouse or indirectly in
terms of preimplantation losses. As numer-
ator and denominator are contributory to
the mutagenic index, estimates of standard
deviation are complex.
Initial testing may reasonably be re-
stricted to meiotic and postmeiotic stages,
for no chemical has been shown to induce
dominant-lethal mutations exclusively in
premeiotic stages. While various chemicals
induce premeiotic effects, as measured by
early fetal deaths and/or preimplantation
losses (5, 7, 8), these also produce marked
meiotic and/or post-meiotic effects. Muta-
genic effects in acute, subacute, or chronic
testing, as measured directly by increased
early fetal deaths and/or indirectly by pre-
implantation losses, should be confirmed by
subsequent testing inter alia over extended
dose ranges. The dominant-lethal assay can
also be used to investigate the possibility of
synergistic, antagonistic or other interactive
mutagenic effects; for example, caffeine is
nonmutagenic and does not synergize the
mutagenic effects of x-rays or chemical mu-
tagens in mice (20).
Recent Experience with the Modified
Dominant Lethal Assay
A total of 174 test agents, including phar-
maceuticals, food additives, pesticides, and
organic extracts of air and water pollutants,
have recently been tested for mutagenicity
in mice using the modified dominant-lethal
assay (1,8). In concurrent control popula-
tions, the mean weekly pregnancy rate was
66% and exceeded 30%o in 99%o of all weeks;
the distribution of weekly mean total im-
plants per pregnancy was symmetrical
around a peak of 11.5-11.9 and was never
less than 8; mean early fetal deaths per
pregnancy were 0.95 in 99.6% of weeks,
and their distribution was highly asym-
metrical. These parameters afforded the
basis for screening the large body of test
data (18).
All agents with mean weekly values be-
yond control limits were subject to analysis
of variance for test and concurrent control
data in all replicate experiments. Less than
10%o of all agents tested were unequivocally
mutagenic as determined directly by in-
creased early fetal deaths per pregnancy
and, in some instances, also indirectly by
reduction in total implants per pregnancy;
the majority of these are known alkylating
agents. Additionally, about 5% of all agents
tested yielded data which fell beyond con-
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5% by analysis of variance, but which,
however, require further replication because
of internal inconsistencies (18).
Essential Stages in the Development of
the Dominant-Lethal Assay
Prior to the use of the dominant-lethal
assay for screening for mutagenic effects, it
is essential that careful and prolonged study
and characterization of the reproductive
parameters of the test rodent colony be
undertaken. The range and pattern of cyclic
and seasonal variation in incidence of preg-
nancies, numbers of total implants, preim-
plantation losses, and early and late fetal
deaths in control animals must be statis-
tically analyzed. Quality control limits must
then be defined which establish limits of
control ranges. On the basis of these limits,
standard criteria may be developed for muta-
genic activity of compounds under test (18).
Data for any test agents meeting these
standard criteria for mutagenicity should
then be subject to analysis of variance and
examined for internal consistency. Positive
results should be confirmed by replication
and by testing over extended dose ranges
(18). Failure to recognize the critical impor-
tance of these problems may well result in
experimentally simplistic approaches to the
dominant-lethal assay and the development
of inadequate and unreliable data, partic-
ularly false positive results.
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